JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
XERS Financials - Xeris Biopharma Holdings. Income & Cash Flow | Ledgeburg
XERS - Xeris Biopharma Holdings. Inc.
USD | NASDAQ | Healthcare
Summary
Summary XERS Stock
Financials
Financials XERS Stock
Loading...
Loading...
Income Statement
Income Statement XERS Stock
Balance Sheet
Balance Sheet XERS Stock
Cash Flow Statement
Cash Flow Statement XERS Stock
Loading...
Loading...
Home
Stocks
Xeris Biopharma Holdings. Inc. (XERS)
Financials
Financials of XERS
Loading...
Loading...
Loading...
Loading...
Revenue
$291.845M
Operating Income
$24.896M
Net Income
$554K
Share Count (Basic)
160.425198M
Operating Cash Flow
$28.626M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$111.042M
Total Debt
$220.335M
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
20M
40M
60M
80M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-100M
-50M
0
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-250%
-200%
-150%
-100%
-50%
0%
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-10M
-5M
0
5M
10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-20%
-10%
0%
10%
20%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26